Advent Pharma Ltd.
Advent Pharma Ltd., a prominent player in the pharmaceutical industry, is headquartered in Bangladesh (BD) and has established a significant presence across various operational regions. Founded in 2004, the company has achieved notable milestones, positioning itself as a trusted provider of high-quality medicines and healthcare solutions. Specialising in the development and manufacturing of generic pharmaceuticals, Advent Pharma offers a diverse portfolio that includes formulations for chronic and acute conditions. Their commitment to innovation and quality sets them apart in a competitive market, ensuring that they meet the evolving needs of healthcare professionals and patients alike. With a strong focus on research and development, Advent Pharma Ltd. has garnered recognition for its contributions to the industry, solidifying its market position as a reliable source of effective and affordable medications.
DitchCarbon Score
How does Advent Pharma Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Advent Pharma Ltd.'s score of 10 is lower than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Advent Pharma Ltd.'s reported carbon emissions
Advent Pharma Ltd., headquartered in Bangladesh (BD), currently does not have any publicly available carbon emissions data or specific reduction targets. Without reported emissions figures, it is challenging to assess their carbon footprint or the scope of their emissions (Scope 1, 2, or 3). However, the absence of data does not preclude the company from engaging in climate commitments or initiatives. In the pharmaceutical industry, companies are increasingly recognising the importance of sustainability and are often encouraged to adopt science-based targets to reduce their greenhouse gas emissions. As Advent Pharma Ltd. continues to navigate the evolving landscape of climate responsibility, it may consider establishing measurable targets and reporting frameworks to enhance transparency and accountability in its environmental impact.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Advent Pharma Ltd. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
